Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Stanford University
Washington University School of Medicine
Washington University School of Medicine
Washington University School of Medicine
Washington University School of Medicine